Keywords: Eisia, Fycompa, Ph III pivotal trial, Epilesy

Positive final pivotal Ph III results for Eisai's Fycompa

Article | 21 August 2012

Print This

Results from the final pivotal Phase III study and long term Phase III extension study of Japanese drug major Eisai& ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in